The iconic rise of Viagra has long been a example of pharmaceutical success, yet its future within the broader sector now raises questions about long-term gains. Generic versions are eroding patent protection , prompting concerns that betting on companies closely tied to Viagra's previous influence could be a speculative move , especially given ong